Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Convalescent plasma in outpatients with COVID-19
Daniele Focosi, Arturo Casadevall
The Lancet Respiratory Medicine (2022) Vol. 10, Iss. 3, pp. 226-228
Open Access | Times Cited: 11

Showing 11 citing articles:

Convalescent plasma therapy in COVID-19: Unravelling the data using the principles of antibody therapy
Arturo Casadevall, Michael J. Joyner, Liise-anne Pirofski, et al.
Expert Review of Respiratory Medicine (2023) Vol. 17, Iss. 5, pp. 381-395
Closed Access | Times Cited: 25
Mortality rates among hospitalized patients with COVID-19 treated with convalescent plasma A Systematic review and meta-analysis
Jonathon W. Senefeld, Ellen K. Gorman, Patrick W. Johnson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 7
COVID-19: Variants, Immunity, and Therapeutics for Non-Hospitalized Patients
Cameron Y. S. Lee, Jon B. Suzuki
Biomedicines (2023) Vol. 11, Iss. 7, pp. 2055-2055
Open Access | Times Cited: 5
Blood Banking Capacity in Low-and Middle-Income Countries: Covid-19 Convalescent Plasma in Context
Evan M. Bloch
Current topics in microbiology and immunology (2024)
Closed Access | Times Cited: 1
Efficacy of convalescent plasma in hospitalized COVID-19 patients: findings from a controlled trial
Tânia Portella Costa, Mateus Nóbrega Aoki, Camilla Moreira Ribeiro, et al.
Brazilian Journal of Medical and Biological Research (2024) Vol. 57
Open Access | Times Cited: 1
Lipid nanoparticle-mRNA: another step in the fight against COVID-19
Abhishek Kumar Verma, Stanley Perlman
Cell Research (2022) Vol. 32, Iss. 5, pp. 421-422
Open Access | Times Cited: 8
Pathogen reduction technologies need to evaluate Fc‐mediated antibody functions
Daniele Focosi, Arturo Casadevall
Transfusion (2022) Vol. 62, Iss. 8, pp. 1680-1681
Closed Access | Times Cited: 8
Hyperimmune Plasma and Immunoglobulins Against COVID-19: A Narrative Review
Massimo Franchini, Daniele Focosi
(2023)
Open Access | Times Cited: 4
The Efficiency of Convalescent Plasma Therapy in the Management of Critically Ill Patients Infected With COVID-19: A Matched Cohort Study
Chun Pan, Hui Chen, Jianfeng Xie, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 7
Home and Out-of-Hospital Therapy with COVID-19 Convalescent Plasma in Europe
Daniele Focosi, Massimo Franchini
Life (2022) Vol. 12, Iss. 11, pp. 1704-1704
Open Access | Times Cited: 1
Pathogen reduction with methylene blue does not have an impact on the clinical effectiveness of COVID‐19 convalescent plasma
Irene Romera, J.L. Bueno Cabrera, José María Domingo‐Morera, et al.
Vox Sanguinis (2023) Vol. 118, Iss. 4, pp. 296-300
Closed Access
Page 1

Scroll to top